Standard
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial. / Idorn, T.; Knop, F. K.; Jorgensen, M. B.; Jensen, T.; Resuli, M.; Hansen, P. M.; Christensen, Karl Bang; Holst, J. J.; Hornum, M.; Feldt-Rasmussen, B.
I:
Diabetologia, Bind 57, Nr. 1 supplement, 909, 09.2014, s. S370-S371.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Idorn, T
, Knop, FK, Jorgensen, MB, Jensen, T, Resuli, M, Hansen, PM
, Christensen, KB, Holst, JJ, Hornum, M & Feldt-Rasmussen, B 2014, '
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial',
Diabetologia, bind 57, nr. 1 supplement, 909, s. S370-S371.
https://doi.org/10.1007/s00125-014-3355-0APA
Idorn, T.
, Knop, F. K., Jorgensen, M. B., Jensen, T., Resuli, M., Hansen, P. M.
, Christensen, K. B., Holst, J. J., Hornum, M., & Feldt-Rasmussen, B. (2014).
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial.
Diabetologia,
57(1 supplement), S370-S371. [909].
https://doi.org/10.1007/s00125-014-3355-0Vancouver
Idorn T
, Knop FK, Jorgensen MB, Jensen T, Resuli M, Hansen PM o.a.
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial.
Diabetologia. 2014 sep.;57(1 supplement):S370-S371. 909.
https://doi.org/10.1007/s00125-014-3355-0Author
Idorn, T. ; Knop, F. K. ; Jorgensen, M. B. ; Jensen, T. ; Resuli, M. ; Hansen, P. M. ; Christensen, Karl Bang ; Holst, J. J. ; Hornum, M. ; Feldt-Rasmussen, B. / Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial. I: Diabetologia. 2014 ; Bind 57, Nr. 1 supplement. s. S370-S371.
Bibtex
@article{d72cb16f8e1746daa2fd21da4bf04e55,
title = "Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial",
author = "T. Idorn and Knop, {F. K.} and Jorgensen, {M. B.} and T. Jensen and M. Resuli and Hansen, {P. M.} and Christensen, {Karl Bang} and Holst, {J. J.} and M. Hornum and B. Feldt-Rasmussen",
year = "2014",
month = sep,
doi = "10.1007/s00125-014-3355-0",
language = "English",
volume = "57",
pages = "S370--S371",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "1 supplement",
}
RIS
TY - ABST
T1 - Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial
AU - Idorn, T.
AU - Knop, F. K.
AU - Jorgensen, M. B.
AU - Jensen, T.
AU - Resuli, M.
AU - Hansen, P. M.
AU - Christensen, Karl Bang
AU - Holst, J. J.
AU - Hornum, M.
AU - Feldt-Rasmussen, B.
PY - 2014/9
Y1 - 2014/9
U2 - 10.1007/s00125-014-3355-0
DO - 10.1007/s00125-014-3355-0
M3 - Conference abstract in journal
C2 - 25134689
VL - 57
SP - S370-S371
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - 1 supplement
M1 - 909
ER -
